Drug Type Small molecule drug |
Synonyms Compound 19(CHIESI Farmaceutici SpA) |
Action antagonists, agonists |
Mechanism mAChRs antagonists(Muscarinic acetylcholine receptor antagonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H30N4O5 |
InChIKeyMNOKODMLZOKTKP-DQEYMECFSA-N |
CAS Registry1613414-68-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Respiratory Diseases | Preclinical | Italy | 28 Jul 2022 |





